WTF with Optiscan: taking pathology to the digital era

Stockheads
04-01

What the Facts on the field of pathology? How does it work? Why modern day pathology is still analogue? What  difficulties do pathologist face?

Pathology still lives in the analogue world when the rest of us live in a digital world. Optiscan (ASX:OIL) CEO and managing director Dr Camile Farah  has the experience and know-how to give Stockhead TV the skinny on the workflow of a pathologist.

Stockhead’s Fraser Palamara sits down with Camile to look at the world of pathology and how Optiscan could finally take pathology into the digital world.

This video was developed in collaboration with Optiscan, a Stockhead advertiser at the time of publishing.

This video does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.

Explore More

  • Investor Guide: Health & Biotech FY2025 featuring Tim Boreham

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10